Alumis reports positive outcomes from Phase I trial of TYK2 inhibitor
Alumis has revealed encouraging results from a Phase I clinical trial of a selective tyrosine kinase 2 (TYK2) inhibitor, A-005,…
Central Nervous System
-
-
MindMed doses first subject in trial of tablets for generalised anxiety disorder
US-based biotechnology company Mind Medicine (MindMed) has dosed the first subject in the 52-week Phase III Voyage study of MM120…
-
AbbVie’s Phase III trial of Parkinson’s disease treatment meets primary endpoint
US-based pharmaceutical company AbbVie has reported that the Phase III TEMPO-2 trial of tavapadon, its D1/D5 partial agonist candidate for…
-
BioArctic doses first subject in Parkinson’s disease therapy trial
BioArctic has dosed the first subject with the monoclonal antibody, exidavnemab, in the randomised Phase IIa EXIdavnemab Synucleinopathy Trial (EXIST)…
-
Nuvig secures $161m financing to support clinical studies for NVG-2089
Nuvig Therapeutics has closed a $161m Series B financing round to advance its preclinical pipeline and support NVG-2089’s clinical proof-of-concept…
-
Teva reports positive outcomes from episodic migraine trial in young patients
Teva Pharmaceutical Industries has reported positive outcomes from its multicentre Phase III SPACE trial of Ajovy (fremanezumab) as a preventive…
-
Gate Neurosciences and Pitt commence antidepressant drug trial
Gate Neurosciences and the University of Pittsburgh (Pitt) have commenced a Phase II clinical trial to evaluate the potential of…
-
Sudo Biosciences begins trial of drug candidate for neuroinflammatory conditions
US-based biopharmaceutical company Sudo Biosciences has initiated a Phase I trial of SUDO-550, a drug candidate designed to treat neuroinflammatory…
-
S.BIOMEDICS reports positive data from Parkinson’s trial of TED-A9 cell therapy
S.BIOMEDICS has reported encouraging one-year post-transplant outcomes from a Phase I/IIa study of its cell therapy, TED-A9, for treating Parkinson's…
-
Neuralink to launch feasibility trial with implant coupled to robotic arm
US-based Neuralink has received approval to launch a new feasibility trial studying its brain implant linked with an assistive robotic…
